Company Overview
- Website
- alzamend.com
- Phone
- (844) 722-6333
- Employees
- 9
- Founded in
- 2016
- Industry
- Scientific Research
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services5417 - Scientific Research and Development Services54171 - Research and Development in the Physical, Engineering, and Life Sciences541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- SIC Codes
-
87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$11B
Recent News & Media
Fast-Tracked: $5M Investment Accelerates 5 Phase II Trials for Alzheimer's and Mental Health Breakthroughs
- Jun 16, 2025
- stocktitan.net
Novel Lithium Drug Enters Phase II Trial, Targets 43M Patients With Brain Disorders Without Blood Monitoring
- May 29, 2025
- stocktitan.net
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants
- May 13, 2025
- finance.yahoo.com
Alzamend Neuro Announces Reverse Stock Split | ALZN Stock News
- May 8, 2025
- stocktitan.net
Alzamend Neuro Announces Reverse Stock Split
- May 8, 2025
- globenewswire.com
EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program
- May 7, 2025
- finance.yahoo.com
Who is Alzamend Neuro Inc
Alzamend Neuro Inc. is a privately held company located in Atlanta, Georgia. The company employs 9 people and reports annual revenue of $11 million. Alzamend Neuro Inc. focuses on biotechnology research and development. The company is currently seeking investors through a $50 million mini-IPO. Alzamend Neuro Inc. is dedicated to developing innovative solutions in the field of biomedicine. For more information, please visit alzamend.com.